tretinoin has been researched along with Anemia--Sideroblastic* in 1 studies
1 trial(s) available for tretinoin and Anemia--Sideroblastic
Article | Year |
---|---|
Effect of 13-cis-retinoic acid on survival of patients with myelodysplastic syndrome.
A randomised therapeutic trial of 13-cis-retinoic acid was carried out in 70 patients with myelodysplastic syndrome having 5% or fewer marrow blast cells. Among non-sideroblastic patients the 1-year survival in the treated group was 77%, compared with 36% in the control group. There were too few deaths among patients with sideroblastic anaemia to allow any effect of therapy on survival to be evaluated. Topics: Adult; Aged; Aged, 80 and over; Anemia, Sideroblastic; Clinical Trials as Topic; Female; Humans; Isomerism; Isotretinoin; Male; Middle Aged; Myelodysplastic Syndromes; Random Allocation; Tretinoin | 1987 |